216 related articles for article (PubMed ID: 8281626)
21. Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.
Haber M; Reed C; Kavallaris M; Norris MD; Stewart BW
J Natl Cancer Inst; 1989 Aug; 81(16):1250-4. PubMed ID: 2754745
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine.
Hofmann J; Wolf A; Spitaler M; Böck G; Drach J; Ludescher C; Grunicke H
J Cancer Res Clin Oncol; 1992; 118(5):361-6. PubMed ID: 1349891
[TBL] [Abstract][Full Text] [Related]
23. In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
Nüssler V; Pelka-Fleisc R; Gieseler F; Hasmann M; Löser R; Gullis E; Stötzer O; Zwierzina H; Wilmanns W
Leuk Lymphoma; 1998 Nov; 31(5-6):589-97. PubMed ID: 9922050
[TBL] [Abstract][Full Text] [Related]
24. In vivo reversibility of multidrug resistance by the MDR-modulator dexniguldipine (niguldipine derivative B859-35) and by verapamil.
Dietel M; Boss H; Reymann A; Pest S; Seidel A
J Exp Ther Oncol; 1996 Jan; 1(1):23-9. PubMed ID: 9414385
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
Berti E; Carrara M; Ragazzi E; D'Ancona S; Berti T
Int J Oncol; 1999 Jul; 15(1):155-60. PubMed ID: 10375609
[TBL] [Abstract][Full Text] [Related]
26. Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.
Roberts DW; Foglesong PD; Parganas E; Wiggins L
Cancer Chemother Pharmacol; 1989; 23(3):161-8. PubMed ID: 2538249
[TBL] [Abstract][Full Text] [Related]
27. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
Huet S; Chapey C; Robert J
Eur J Cancer; 1993; 29A(10):1377-83. PubMed ID: 8398262
[TBL] [Abstract][Full Text] [Related]
28. Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.
Hu XF; Martin TJ; Bell DR; de Luise M; Zalcberg JR
Cancer Res; 1990 May; 50(10):2953-7. PubMed ID: 2334897
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and chemical characterization of 2-methoxy-N(10)-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells.
Krishnegowda G; Thimmaiah P; Hegde R; Dass C; Houghton PJ; Thimmaiah KN
Bioorg Med Chem; 2002 Jul; 10(7):2367-80. PubMed ID: 11983534
[TBL] [Abstract][Full Text] [Related]
30. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
31. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
Chao NJ; Aihara M; Blume KG; Sikic BI
Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.
Kavallaris M; Haber M; Norris MD; Pittman SM; Reed C; Stewart BW
Cancer Lett; 1990 Jun; 51(3):193-201. PubMed ID: 1972035
[TBL] [Abstract][Full Text] [Related]
33. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Kim R; Beck WT
Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
[TBL] [Abstract][Full Text] [Related]
34. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
[TBL] [Abstract][Full Text] [Related]
35. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
36. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
[TBL] [Abstract][Full Text] [Related]
37. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
38. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
39. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
[TBL] [Abstract][Full Text] [Related]
40. Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance.
Le Bot MA; Kernaleguen D; Robert J; Berlion M; Riché C
Cancer Chemother Pharmacol; 1994; 35(1):53-8. PubMed ID: 7987977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
